IND, Clinical Trail for small-molecule and biologics, NDA, Marketing Submission for small-molecule drugs, Class 1 MD, Mostly Exempt or 510 (k), Class 2 MD, 510 (k) for substantially equivalent MD, Class 3 MD, PreMarkter Approval, Class 1 & 2 Noval MD, De Novo, HDE, For rare disease or condition affecting fewer than 8000 individual per year in US, Office of combination products, Confirm which is the lead and the respective pathway

Test

由
打印
嵌入

视觉风格

显示所有
活动设置 排行榜 作业

活动设置

排行榜

更像是这样

GN - NI
GN - NI
由
问答游戏
GN - NI
GN - NI
由
随堂测验
Drug Categories
Drug Categories
由
按组分配
GN/NI
GN/NI
由
随堂测验
NMT 1 (advertisement)
NMT 1 (advertisement)
由
随堂测验
NMT 4 (advertisement)
NMT 4 (advertisement)
由
随堂测验
NMT 10 (advertisement)
NMT 10 (advertisement)
由
随堂测验
NMT 11 (advertisement)
NMT 11 (advertisement)
由
随堂测验

切换模板

恢复自动保存：？